000181264 001__ 181264
000181264 005__ 20240301130854.0
000181264 0247_ $$2doi$$a10.3389/fnhum.2017.00600
000181264 0247_ $$2pmid$$apmid:29276483
000181264 0247_ $$2pmc$$apmc:PMC5727042
000181264 0247_ $$2altmetric$$aaltmetric:29498501
000181264 037__ $$aDKFZ-2022-01907
000181264 041__ $$aEnglish
000181264 082__ $$a610
000181264 1001_ $$aOberste, Max$$b0
000181264 245__ $$aControl Group Paradigms in Studies Investigating Acute Effects of Exercise on Cognitive Performance-An Experiment on Expectation-Driven Placebo Effects.
000181264 260__ $$aLausanne$$bFrontiers Research Foundation$$c2017
000181264 3367_ $$2DRIVER$$aarticle
000181264 3367_ $$2DataCite$$aOutput Types/Journal article
000181264 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1660900427_30652
000181264 3367_ $$2BibTeX$$aARTICLE
000181264 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000181264 3367_ $$00$$2EndNote$$aJournal Article
000181264 500__ $$aPOF Topic: 317
000181264 520__ $$aIntroduction: Many studies report improvements in cognitive performance following acute endurance exercise compared to control group treatment. These cognitive benefits are interpreted as a result of a physiological response to exercise. However, it was also hypothesized that expectation-driven placebo effects account for these positive effects. The purpose of this study was to investigate the differences between expectations for cognitive benefits toward acute endurance exercise and multiple control group treatments. Methods: Healthy individuals (N = 247, 24.26 ± 3.88 years) were randomized to eight different groups watching videos of a moderate, a vigorous exercise treatment or one control group treatment (waiting, reading, video-watching, stretching, myofascial release workout, and very light exercise). Then, they were introduced to three commonly used cognitive test procedures in acute exercise-cognition research (Stroop-test, Trail-Making-test, Free-recall-task). Participants rated the effect they would expect on their performance in those tasks, if they had received the treatment shortly before the task, on an 11-point Likert scale. Results: No significantly different expectations for cognitive benefits toward acute moderate exercise and control group treatments could be revealed. Participants expected significantly worse performance following vigorous exercise compared to following waiting and stretching for all cognitive tests. Significantly worse performance after vigorous exercise compared to after very light exercise was expected for Stroop and Free-recall. For Free-recall, participants expected worse performance after vigorous exercise compared to myofascial release training as well. Conclusion: Our results indicate that expectation-driven placebo effects are unlikely to cause the reported greater cognitive improvements following acute moderate and vigorous endurance exercise compared to following common control group treatments.
000181264 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000181264 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000181264 650_7 $$2Other$$aacute exercise
000181264 650_7 $$2Other$$acognition
000181264 650_7 $$2Other$$acontrol group
000181264 650_7 $$2Other$$aexpectation
000181264 650_7 $$2Other$$amemory
000181264 650_7 $$2Other$$aplacebo effect
000181264 7001_ $$aHartig, Philipp$$b1
000181264 7001_ $$aBloch, Wilhelm$$b2
000181264 7001_ $$aElsner, Benjamin$$b3
000181264 7001_ $$aPredel, Hans-Georg$$b4
000181264 7001_ $$aErnst, Bernhard$$b5
000181264 7001_ $$0P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aZimmer, Philipp$$b6$$eLast author
000181264 773__ $$0PERI:(DE-600)2425477-0$$a10.3389/fnhum.2017.00600$$gVol. 11, p. 600$$p600$$tFrontiers in human neuroscience$$v11$$x1662-5161$$y2017
000181264 909CO $$ooai:inrepo02.dkfz.de:181264$$pVDB
000181264 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000181264 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000181264 9141_ $$y2017
000181264 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT HUM NEUROSCI : 2019$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-01-27
000181264 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-27
000181264 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-01-27
000181264 9201_ $$0I:(DE-He78)G210-20160331$$kG210$$lBewegung, Präventionsforschung und Krebs$$x0
000181264 980__ $$ajournal
000181264 980__ $$aVDB
000181264 980__ $$aI:(DE-He78)G210-20160331
000181264 980__ $$aUNRESTRICTED